These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 22653270)
1. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270 [TBL] [Abstract][Full Text] [Related]
2. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118 [TBL] [Abstract][Full Text] [Related]
3. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Oudit GY; Liu GC; Zhong J; Basu R; Chow FL; Zhou J; Loibner H; Janzek E; Schuster M; Penninger JM; Herzenberg AM; Kassiri Z; Scholey JW Diabetes; 2010 Feb; 59(2):529-38. PubMed ID: 19934006 [TBL] [Abstract][Full Text] [Related]
4. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Gurley SB; Mach CL; Stegbauer J; Yang J; Snow KP; Hu A; Meyer TW; Coffman TM Am J Physiol Renal Physiol; 2010 Mar; 298(3):F788-95. PubMed ID: 20042456 [TBL] [Abstract][Full Text] [Related]
5. p47(phox) contributes to albuminuria and kidney fibrosis in mice. Wang H; Chen X; Su Y; Paueksakon P; Hu W; Zhang MZ; Harris RC; Blackwell TS; Zent R; Pozzi A Kidney Int; 2015 May; 87(5):948-62. PubMed ID: 25565313 [TBL] [Abstract][Full Text] [Related]
6. Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse. Fang F; Bae EH; Hu A; Liu GC; Zhou X; Williams V; Maksimowski N; Lu C; Konvalinka A; John R; Scholey JW Diabetologia; 2015 Jul; 58(7):1668-78. PubMed ID: 25957229 [TBL] [Abstract][Full Text] [Related]
7. Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice. Nagasu H; Satoh M; Kiyokage E; Kidokoro K; Toida K; Channon KM; Kanwar YS; Sasaki T; Kashihara N Lab Invest; 2016 Jan; 96(1):25-36. PubMed ID: 26552047 [TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Yang Z; Sharma AK; Marshall M; Kron IL; Laubach VE Am J Respir Cell Mol Biol; 2009 Mar; 40(3):375-81. PubMed ID: 18787174 [TBL] [Abstract][Full Text] [Related]
9. Lack of p47(phox) in Akita Diabetic Mice Is Associated with Interstitial Pneumonia, Fibrosis, and Oral Inflammation. Zamakhchari MF; Sima C; Sama K; Fine N; Glogauer M; Van Dyke TE; Gyurko R Am J Pathol; 2016 Mar; 186(3):659-70. PubMed ID: 26747235 [TBL] [Abstract][Full Text] [Related]
11. Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in Ins Itano S; Kadoya H; Satoh M; Nakamura T; Murase T; Sasaki T; Kanwar YS; Kashihara N Am J Physiol Renal Physiol; 2020 Nov; 319(5):F765-F772. PubMed ID: 32954851 [TBL] [Abstract][Full Text] [Related]
12. NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy. Jha JC; Banal C; Okabe J; Gray SP; Hettige T; Chow BSM; Thallas-Bonke V; De Vos L; Holterman CE; Coughlan MT; Power DA; Skene A; Ekinci EI; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm K Diabetes; 2017 Oct; 66(10):2691-2703. PubMed ID: 28747378 [TBL] [Abstract][Full Text] [Related]
13. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318 [TBL] [Abstract][Full Text] [Related]
14. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Zhang L; Pang S; Deng B; Qian L; Chen J; Zou J; Zheng J; Yang L; Zhang C; Chen X; Liu Z; Le Y Int J Biochem Cell Biol; 2012 Apr; 44(4):629-38. PubMed ID: 22245600 [TBL] [Abstract][Full Text] [Related]
15. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641 [TBL] [Abstract][Full Text] [Related]
17. p47 Gong P; Chen YQ; Lin AH; Zhang HB; Zhang Y; Ye RD; Yu Y Alzheimers Res Ther; 2020 Nov; 12(1):146. PubMed ID: 33183342 [TBL] [Abstract][Full Text] [Related]
18. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice. Fujita H; Fujishima H; Morii T; Sakamoto T; Komatsu K; Hosoba M; Narita T; Takahashi K; Takahashi T; Yamada Y Hypertens Res; 2012 Feb; 35(2):213-20. PubMed ID: 22072110 [TBL] [Abstract][Full Text] [Related]
19. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548 [TBL] [Abstract][Full Text] [Related]
20. Renoprotective antioxidant effect of alagebrium in experimental diabetes. Park J; Kwon MK; Huh JY; Choi WJ; Jeong LS; Nagai R; Kim WY; Kim J; Lee GT; Lee HB; Ha H Nephrol Dial Transplant; 2011 Nov; 26(11):3474-84. PubMed ID: 21478303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]